US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist

3.080
+0.150+5.12%

Close Nov 8 16:00 ET

3.080
0.0000.00%

Post 20:01 ET

300.19MMarket Cap-4888P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

215.44%38.45M

60.18%-15.14M

-244.27%-92.17M

-1,296.17%-28.74M

-87.25%7.89M

16.17%-33.31M

25.95%-38.01M

73.89%-26.77M

-71.64%2.4M

251.39%61.88M

Net income from continuing operations

-14.26%-31.37M

37.51%-24.27M

-92.85%-123.43M

23.92%-25.35M

-145.13%-31.78M

36.20%-27.46M

33.09%-38.85M

48.79%-64M

-2,368.07%-33.32M

265.97%70.41M

Operating gains losses

----

-99.14%3K

--0

----

17,500.00%348K

2,960.00%143K

--0

Depreciation and amortization

-4.39%1.35M

4.23%1.38M

8.55%5.61M

6.13%1.44M

6.74%1.44M

11.98%1.41M

9.69%1.32M

13.62%5.17M

14.54%1.36M

15.48%1.35M

Other non cash items

29.06%-1.36M

17.24%-1.63M

-4.27%808K

847.28%6.45M

69.82%-1.76M

14.61%-1.92M

-123.86%-1.97M

32.08%844K

339.35%681K

-3,936.84%-5.83M

Change In working capital

675.00%62.2M

166.76%4M

2.67%14.08M

-125.88%-7.96M

566.69%38.86M

-843.16%-10.82M

20.91%-6M

-32.00%13.72M

45.93%30.77M

-111.48%-8.33M

-Change in receivables

88.47%-400K

-564.00%-3.02M

100.85%77K

-101.15%-338K

108.46%3.23M

-1,394.83%-3.47M

--650K

---9.09M

--29.38M

---38.24M

-Change in prepaid assets

37.93%1.8M

-144.90%-854K

213.63%1.57M

-104.54%-31K

-34.14%-1.61M

-22.51%1.31M

385.16%1.9M

118.79%499K

221.96%683K

68.63%-1.2M

-Change in payables and accrued expense

131.97%4.38M

10.11%-5.92M

212.96%6.04M

381.89%8.3M

341.57%2.44M

6,196.67%1.89M

-8.06%-6.59M

-180.58%-5.35M

-69.57%1.72M

-1,668.42%-1.01M

-Change in other current assets

11.35%893K

-0.68%871K

-36.01%3.33M

-15.17%850K

-39.75%805K

-34.48%802K

-46.78%877K

-5.91%5.21M

-67.32%1M

54.99%1.34M

-Change in other current liabilities

-14.08%-1.01M

-2.99%-963K

24.38%-3.67M

11.27%-937K

34.03%-909K

35.88%-888K

9.49%-935K

-55.86%-4.85M

-24.97%-1.06M

-50.93%-1.38M

-Change in other working capital

640.65%56.54M

828.82%13.88M

-75.34%6.73M

-1,543.35%-15.81M

8.53%34.9M

-323.74%-10.46M

-32.75%-1.91M

98.34%27.3M

---962K

--32.16M

Cash from discontinued investing activities

Operating cash flow

215.44%38.45M

60.18%-15.14M

-244.27%-92.17M

-1,296.17%-28.74M

-87.25%7.89M

16.17%-33.31M

25.95%-38.01M

73.89%-26.77M

-71.64%2.4M

251.39%61.88M

Investing cash flow

Cash flow from continuing investing activities

-242.09%-61.2M

643.67%24M

119.25%39.13M

155.55%47.71M

-31.68%-47.24M

153.29%43.07M

-494.21%-4.42M

-191.43%-203.33M

-43,946.15%-85.89M

-196.60%-35.87M

Net PPE purchase and sale

13.94%-1.02M

83.42%-130K

21.63%-3.07M

-18.85%-309K

53.34%-789K

2.79%-1.18M

-5.52%-784K

-49.54%-3.91M

-33.33%-260K

-363.29%-1.69M

Net investment purchase and sale

-235.99%-60.18M

764.64%24.13M

121.16%42.2M

156.08%48.02M

-35.89%-46.45M

155.59%44.26M

---3.63M

-188.63%-199.42M

---85.63M

-191.15%-34.18M

Cash from discontinued investing activities

Investing cash flow

-242.09%-61.2M

643.67%24M

119.25%39.13M

155.55%47.71M

-31.68%-47.24M

153.29%43.07M

-494.21%-4.42M

-191.43%-203.33M

-43,946.15%-85.89M

-196.60%-35.87M

Financing cash flow

Cash flow from continuing financing activities

-103.63%-43K

-84.66%16.13M

-80.30%14.94M

-95.94%1.19M

4,076.29%105.16M

-75.42%58K

3,988.30%75.84M

Net issuance payments of debt

----

--0

----

--30M

--0

Net common stock issuance

--0

-79.62%15.35M

--0

-80.85%14.42M

--0

--928K

--75.3M

--0

--75.3M

Proceeds from stock option exercised by employees

--0

-26.99%549K

-2.60%1.28M

--0

-2.78%524K

--0

10.43%752K

-47.97%1.31M

-75.42%58K

-70.94%539K

Net other financing activities

--0

-19.84%-592K

65.93%-494K

--0

65.93%-494K

---1.45M

--0

Cash from discontinued financing activities

Financing cash flow

--0

-103.63%-43K

-84.66%16.13M

--0

-80.30%14.94M

--0

-95.94%1.19M

4,076.29%105.16M

-75.42%58K

3,988.30%75.84M

Net cash flow

Beginning cash position

32.76%53.3M

-45.35%44.47M

-60.56%81.38M

-84.53%25.5M

-20.73%49.91M

-78.12%40.14M

-60.56%81.38M

145.72%206.33M

-16.68%164.81M

-68.47%62.96M

Current changes in cash

-332.95%-22.75M

121.40%8.83M

70.46%-36.91M

122.74%18.97M

-123.97%-24.41M

108.10%9.77M

-80.57%-41.23M

-202.12%-124.95M

-1,079.90%-83.43M

5,511.48%101.84M

End cash Position

-38.80%30.55M

32.76%53.3M

-45.35%44.47M

-84.53%25.5M

-20.73%49.91M

-78.12%40.14M

-60.56%81.38M

-16.68%164.81M

Free cash flow

208.53%37.43M

60.65%-15.27M

-210.25%-95.23M

-1,455.72%-29.05M

-88.20%7.1M

15.77%-34.49M

25.50%-38.79M

70.81%-30.7M

-74.06%2.14M

245.92%60.18M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	215.44%38.45M	60.18%-15.14M	-244.27%-92.17M	-1,296.17%-28.74M	-87.25%7.89M	16.17%-33.31M	25.95%-38.01M	73.89%-26.77M	-71.64%2.4M	251.39%61.88M
Net income from continuing operations	-14.26%-31.37M	37.51%-24.27M	-92.85%-123.43M	23.92%-25.35M	-145.13%-31.78M	36.20%-27.46M	33.09%-38.85M	48.79%-64M	-2,368.07%-33.32M	265.97%70.41M
Operating gains losses	----	----	-99.14%3K	--0	----	----	----	17,500.00%348K	2,960.00%143K	--0
Depreciation and amortization	-4.39%1.35M	4.23%1.38M	8.55%5.61M	6.13%1.44M	6.74%1.44M	11.98%1.41M	9.69%1.32M	13.62%5.17M	14.54%1.36M	15.48%1.35M
Other non cash items	29.06%-1.36M	17.24%-1.63M	-4.27%808K	847.28%6.45M	69.82%-1.76M	14.61%-1.92M	-123.86%-1.97M	32.08%844K	339.35%681K	-3,936.84%-5.83M
Change In working capital	675.00%62.2M	166.76%4M	2.67%14.08M	-125.88%-7.96M	566.69%38.86M	-843.16%-10.82M	20.91%-6M	-32.00%13.72M	45.93%30.77M	-111.48%-8.33M
-Change in receivables	88.47%-400K	-564.00%-3.02M	100.85%77K	-101.15%-338K	108.46%3.23M	-1,394.83%-3.47M	--650K	---9.09M	--29.38M	---38.24M
-Change in prepaid assets	37.93%1.8M	-144.90%-854K	213.63%1.57M	-104.54%-31K	-34.14%-1.61M	-22.51%1.31M	385.16%1.9M	118.79%499K	221.96%683K	68.63%-1.2M
-Change in payables and accrued expense	131.97%4.38M	10.11%-5.92M	212.96%6.04M	381.89%8.3M	341.57%2.44M	6,196.67%1.89M	-8.06%-6.59M	-180.58%-5.35M	-69.57%1.72M	-1,668.42%-1.01M
-Change in other current assets	11.35%893K	-0.68%871K	-36.01%3.33M	-15.17%850K	-39.75%805K	-34.48%802K	-46.78%877K	-5.91%5.21M	-67.32%1M	54.99%1.34M
-Change in other current liabilities	-14.08%-1.01M	-2.99%-963K	24.38%-3.67M	11.27%-937K	34.03%-909K	35.88%-888K	9.49%-935K	-55.86%-4.85M	-24.97%-1.06M	-50.93%-1.38M
-Change in other working capital	640.65%56.54M	828.82%13.88M	-75.34%6.73M	-1,543.35%-15.81M	8.53%34.9M	-323.74%-10.46M	-32.75%-1.91M	98.34%27.3M	---962K	--32.16M
Cash from discontinued investing activities
Operating cash flow	215.44%38.45M	60.18%-15.14M	-244.27%-92.17M	-1,296.17%-28.74M	-87.25%7.89M	16.17%-33.31M	25.95%-38.01M	73.89%-26.77M	-71.64%2.4M	251.39%61.88M
Investing cash flow
Cash flow from continuing investing activities	-242.09%-61.2M	643.67%24M	119.25%39.13M	155.55%47.71M	-31.68%-47.24M	153.29%43.07M	-494.21%-4.42M	-191.43%-203.33M	-43,946.15%-85.89M	-196.60%-35.87M
Net PPE purchase and sale	13.94%-1.02M	83.42%-130K	21.63%-3.07M	-18.85%-309K	53.34%-789K	2.79%-1.18M	-5.52%-784K	-49.54%-3.91M	-33.33%-260K	-363.29%-1.69M
Net investment purchase and sale	-235.99%-60.18M	764.64%24.13M	121.16%42.2M	156.08%48.02M	-35.89%-46.45M	155.59%44.26M	---3.63M	-188.63%-199.42M	---85.63M	-191.15%-34.18M
Cash from discontinued investing activities
Investing cash flow	-242.09%-61.2M	643.67%24M	119.25%39.13M	155.55%47.71M	-31.68%-47.24M	153.29%43.07M	-494.21%-4.42M	-191.43%-203.33M	-43,946.15%-85.89M	-196.60%-35.87M
Financing cash flow
Cash flow from continuing financing activities	0	-103.63%-43K	-84.66%16.13M	0	-80.30%14.94M	0	-95.94%1.19M	4,076.29%105.16M	-75.42%58K	3,988.30%75.84M
Net issuance payments of debt	----	----	--0	--0	----	----	----	--30M	--0	--0
Net common stock issuance	--0	--0	-79.62%15.35M	--0	-80.85%14.42M	--0	--928K	--75.3M	--0	--75.3M
Proceeds from stock option exercised by employees	--0	-26.99%549K	-2.60%1.28M	--0	-2.78%524K	--0	10.43%752K	-47.97%1.31M	-75.42%58K	-70.94%539K
Net other financing activities	--0	-19.84%-592K	65.93%-494K	--0	--0	--0	65.93%-494K	---1.45M	--0	--0
Cash from discontinued financing activities
Financing cash flow	--0	-103.63%-43K	-84.66%16.13M	--0	-80.30%14.94M	--0	-95.94%1.19M	4,076.29%105.16M	-75.42%58K	3,988.30%75.84M
Net cash flow
Beginning cash position	32.76%53.3M	-45.35%44.47M	-60.56%81.38M	-84.53%25.5M	-20.73%49.91M	-78.12%40.14M	-60.56%81.38M	145.72%206.33M	-16.68%164.81M	-68.47%62.96M
Current changes in cash	-332.95%-22.75M	121.40%8.83M	70.46%-36.91M	122.74%18.97M	-123.97%-24.41M	108.10%9.77M	-80.57%-41.23M	-202.12%-124.95M	-1,079.90%-83.43M	5,511.48%101.84M
End cash Position	-38.80%30.55M	32.76%53.3M	-45.35%44.47M	-45.35%44.47M	-84.53%25.5M	-20.73%49.91M	-78.12%40.14M	-60.56%81.38M	-60.56%81.38M	-16.68%164.81M
Free cash flow	208.53%37.43M	60.65%-15.27M	-210.25%-95.23M	-1,455.72%-29.05M	-88.20%7.1M	15.77%-34.49M	25.50%-38.79M	70.81%-30.7M	-74.06%2.14M	245.92%60.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data